Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018-2020
Antimicrobial resistance (AMR) can complicate effective management of urinary tract infections (UTIs). We conducted a retrospective study of AMR in Enterobacterales urine isolates from ambulatory and hospitalized adult patients from 2018-2020 (BD Insights Research Database) to evaluate regional differences in isolates with an extended-spectrum beta-lactamase (ESBL)-producing phenotype or not susceptible to beta-lactams, fluoroquinolones (FQ), nitrofurantoin (NFT), trimethoprim/sulfamethoxazole (TMP/SMX), or multiple antibiotic classes (2+ or 3+). Our analyses included 349,741 Enterobacterales urine isolates from 321 inpatient facilities and 980,354 isolates from 338 ambulatory care facilities.
Ambassador Network
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!